Difficulty: Medium
Average Score: 95%
Practice
A 38-year-old man with chronic anxiety and agitation is currently being treated with a long-acting benzodiazepine. He is having challenges with sleep and is referred to a sleep center for a 24-h sleep study to further ascertain his difficulties. Which of the following is the most likely abnormality to be noted on this study?
Correct answer
B
Rationale
In this scenario, the most likely abnormality to be noted on the 24-h sleep study for the 38-year-old man with chronic anxiety and agitation who is being treated with a long-acting benzodiazepine would be "B) Hourly awakening from sleep."
Explanation:
- Benzodiazepines, especially long-acting ones, can disrupt normal sleep architecture by causing frequent awakenings during the night. This leads to a fragmented and poor-quality sleep pattern.
- The individual may experience difficulty in maintaining continuous sleep due to the sedative effects of the benzodiazepine, resulting in frequent arousals throughout the night.
- Hourly awakenings from sleep can contribute to sleep fragmentation, leading to non-restorative sleep and daytime drowsiness, which can exacerbate the existing issues of anxiety and agitation.
Why other options are incorrect:
- A) Calming effect during sleep induction: While benzodiazepines can have a calming effect when initiating sleep, the issue here pertains to maintaining sleep throughout the night.
- C) Hypnotic effect with dreams: This option does not directly address the issue of frequent awakenings during sleep, which is the primary concern in this case.
- D) Improved slow-wave sleep: Benzodiazepines are known to suppress slow-wave sleep, so this option is unlikely to be the abnormality noted in the sleep study.
Educational context:
Understanding the side effects of CNS drugs like benzodiazepines on sleep architecture is crucial for healthcare professionals managing patients with anxiety and sleep disturbances. Monitoring sleep patterns through studies like polysomnography can provide valuable insights into the impact of medications on sleep quality and guide treatment modifications to improve overall patient outcomes.
Explanation:
- Benzodiazepines, especially long-acting ones, can disrupt normal sleep architecture by causing frequent awakenings during the night. This leads to a fragmented and poor-quality sleep pattern.
- The individual may experience difficulty in maintaining continuous sleep due to the sedative effects of the benzodiazepine, resulting in frequent arousals throughout the night.
- Hourly awakenings from sleep can contribute to sleep fragmentation, leading to non-restorative sleep and daytime drowsiness, which can exacerbate the existing issues of anxiety and agitation.
Why other options are incorrect:
- A) Calming effect during sleep induction: While benzodiazepines can have a calming effect when initiating sleep, the issue here pertains to maintaining sleep throughout the night.
- C) Hypnotic effect with dreams: This option does not directly address the issue of frequent awakenings during sleep, which is the primary concern in this case.
- D) Improved slow-wave sleep: Benzodiazepines are known to suppress slow-wave sleep, so this option is unlikely to be the abnormality noted in the sleep study.
Educational context:
Understanding the side effects of CNS drugs like benzodiazepines on sleep architecture is crucial for healthcare professionals managing patients with anxiety and sleep disturbances. Monitoring sleep patterns through studies like polysomnography can provide valuable insights into the impact of medications on sleep quality and guide treatment modifications to improve overall patient outcomes.